Pyxis Oncology, Inc. PYXS
Regular-session close
Pre-market · Nov 16, 7:22 AM ET
- YTD
- +37.39%
- 1 year
- -64.73%
Held by funds
13 US ETFs and mutual funds hold PYXS · largest positions
Ownership
- Institutions 56.5%
- Insiders 24.5%
- Public and other holders 18.9%
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Deep Track Capital, Lp | 7.04% | 4,184,100 | 6.99M | Sep 29, 2024 |
| Laurion Capital Management, LP | 6.10% | 3,625,974 | 6.06M | Sep 29, 2024 |
| Blackrock Inc. | 4.98% | 2,964,160 | 4.95M | Sep 29, 2024 |
| Vanguard Group Inc | 4.09% | 2,432,953 | 4.06M | Sep 29, 2024 |
| Millennium Management Llc | 3.21% | 1,906,978 | 3.18M | Sep 29, 2024 |
| Blue Owl Capital Holdings LP | 1.89% | 1,126,025 | 1.88M | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.18% | 1,294,689 | 2.16M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.07% | 1,231,472 | 2.06M | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 1.32% | 782,884 | 1.31M | Sep 29, 2024 |
| abrdn Healthcare Investors | 1.05% | 626,637 | 1.05M | Sep 29, 2024 |
| Fidelity Small Cap Index Fund | 0.84% | 500,435 | 835.73K | Aug 30, 2024 |
| iShares Russell 2000 Value ETF | 0.83% | 492,033 | 821.70K | Oct 30, 2024 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Board of directors
Who sits on PYXS’s board, from its insider filings
8 directors: 1 executive of the company and 7 who are not.
| Name | Role | Director since | Latest filing |
|---|---|---|---|
| Thomas Civik | CEO & Chairman of the BoardExecutive | Before Apr 2023 | Sep 2026 |
| Darren S. Cline | Director | Before Apr 2023 | Mar 2026 |
| Freda C. Lewis-Hall | Director | Before Apr 2023 | Mar 2026 |
| John L. Flavin | Director | Before Apr 2023 | Mar 2026 |
| Rachel Humphrey | Director | Before Apr 2023 | Nov 2026 |
| Jakob Dupont | Director | Aug 2023 | Aug 2026 |
| Santhosh Palani | Director | Jun 2024 | Mar 2026 |
| Michael A. Metzger | Director | Mar 2025 | Mar 2026 |
Everyone who reported a trade or a grant as a director (SEC Form 4) in the last 15 months. A director who has not filed in that time is missing, and one who left recently can still be listed. “Director since” is the first such filing in our records, which start in 2021; the filings do not say who is independent or who sits on which committee.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CIVIK THOMAS | Director | Stock Award(Grant) | Mar 23, 2023 | 221,886 |
| CLINE DARREN S | Director | Stock Award(Grant) | Mar 25, 2024 | 251,405 |
| CONNEALY PAMELA ANN | Chief Operating Officer | Purchase | Nov 25, 2024 | 0 |
| DUPONT JAKOB | Director | Stock Award(Grant) | Mar 25, 2024 | 38,741 |
| FLAVIN JOHN L. | Director | Stock Award(Grant) | Mar 25, 2024 | 413,015 |
| HUMPHREY RACHEL W M.D. | Director | Stock Award(Grant) | Mar 25, 2024 | 96,805 |
